advertisement
Kumar R 22
Showing records 1 to 22 | Display all abstracts from Kumar R98480 Mutational analysis of (rs56010818) variant in primary open angle glaucoma (POAG) affected patients of Pakistan
Narsani AK
Saudi journal of biological sciences 2022; 29: 96-101
99337 Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors
Kumar A
Bioorganic chemistry 2022; 123: 105764
98238 Novel benzenesulfonamide-bearing pyrazoles and 1,2,4-thiadiazoles as selective carbonic anhydrase inhibitors
Kumar R; Kumar A
Archiv der Pharmazie 2022; 355: e2100241
99337 Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors
Siwach K
Bioorganic chemistry 2022; 123: 105764
98480 Mutational analysis of (rs56010818) variant in primary open angle glaucoma (POAG) affected patients of Pakistan
Waryah AM
Saudi journal of biological sciences 2022; 29: 96-101
98238 Novel benzenesulfonamide-bearing pyrazoles and 1,2,4-thiadiazoles as selective carbonic anhydrase inhibitors
Ram S
Archiv der Pharmazie 2022; 355: e2100241
99337 Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors
Rom T
Bioorganic chemistry 2022; 123: 105764
98480 Mutational analysis of (rs56010818) variant in primary open angle glaucoma (POAG) affected patients of Pakistan
Rafiq M
Saudi journal of biological sciences 2022; 29: 96-101
98238 Novel benzenesulfonamide-bearing pyrazoles and 1,2,4-thiadiazoles as selective carbonic anhydrase inhibitors
Angeli A
Archiv der Pharmazie 2022; 355: e2100241
99337 Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors
Kumar R
Bioorganic chemistry 2022; 123: 105764
98480 Mutational analysis of (rs56010818) variant in primary open angle glaucoma (POAG) affected patients of Pakistan
Shaikh H; Naqvi SHA
Saudi journal of biological sciences 2022; 29: 96-101
98238 Novel benzenesulfonamide-bearing pyrazoles and 1,2,4-thiadiazoles as selective carbonic anhydrase inhibitors
Bonardi A
Archiv der Pharmazie 2022; 355: e2100241
99337 Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors
Angeli A
Bioorganic chemistry 2022; 123: 105764
98480 Mutational analysis of (rs56010818) variant in primary open angle glaucoma (POAG) affected patients of Pakistan
Kumar R
Saudi journal of biological sciences 2022; 29: 96-101
99337 Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors
Kumar Paul A
Bioorganic chemistry 2022; 123: 105764
98238 Novel benzenesulfonamide-bearing pyrazoles and 1,2,4-thiadiazoles as selective carbonic anhydrase inhibitors
Nocentini A
Archiv der Pharmazie 2022; 355: e2100241
99337 Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors
Supuran CT
Bioorganic chemistry 2022; 123: 105764
98238 Novel benzenesulfonamide-bearing pyrazoles and 1,2,4-thiadiazoles as selective carbonic anhydrase inhibitors
Gratteri P
Archiv der Pharmazie 2022; 355: e2100241
98480 Mutational analysis of (rs56010818) variant in primary open angle glaucoma (POAG) affected patients of Pakistan
Kumar P
Saudi journal of biological sciences 2022; 29: 96-101
98238 Novel benzenesulfonamide-bearing pyrazoles and 1,2,4-thiadiazoles as selective carbonic anhydrase inhibitors
Gratteri P; Gratteri P
Archiv der Pharmazie 2022; 355: e2100241
99337 Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors
Sharma PK
Bioorganic chemistry 2022; 123: 105764
98238 Novel benzenesulfonamide-bearing pyrazoles and 1,2,4-thiadiazoles as selective carbonic anhydrase inhibitors
Supuran CT; Sharma PK
Archiv der Pharmazie 2022; 355: e2100241
